首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

2055083

醫用氫可酮市場：依給藥途徑、應用、最終用戶、生產地、濃度、病患年齡層、通路和地區分類

Medical Morphine Market, By Route of Administration, By Application, By End User, By Manufacturing Origin, By Strength, By Patient Age Group, By Distribution Channel, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，2026年醫用氫可酮市值為271.3億美元，預計到2033年將達到461.9億美元。預計從2026年到2033年，其複合年成長率將達到7.9%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	271.3億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	7.90%	2033年市場規模預測：	461.9億美元

全球醫用氫可酮市場是製藥業的重要組成部分，主要集中在氫可酮類藥物的生產、分銷和使用，用於疼痛管理和安寧療護。氫可酮是一種從罌粟提煉的天然鴉片生物鹼，是全球臨床上緩解重度疼痛的黃金標準。這種重要的治療藥物在急性和慢性疼痛的管理中發揮著至關重要的作用，尤其是在術後護理、癌症治療和臨終關懷方面。

醫用氫可酮市場涵蓋多種劑型，旨在滿足特定患者的需求和臨床要求，例如速釋片、緩釋製劑、注射和口服液。醫療專業人員高度依賴氫可酮強大的鎮痛作用來改善患者的生活品質，並確保有效的疼痛管理方案。該市場的重要性不僅限於產生收入，更直接影響全球醫療保健成果和病患福祉。儘管面臨監管挑戰和對鴉片類藥物依賴性的擔憂，醫用氫可酮因其在控制重度疼痛方面無與倫比的療效，在現代醫學中仍然不可或缺。隨著製藥技術的進步、給藥機制的改進和安全性的提升，該行業不斷發展，以最大限度地降低潛在風險，同時保持治療效果。

市場動態

全球醫用氫可酮市場受多種強勁因素驅動，這些因素支撐著其在國際醫療保健體系中的成長勢頭。主要促進因素包括全球慢性疼痛疾病、癌症病例和外科手術數量的不斷增加，這導致對有效疼痛管理解決方案的需求顯著成長。全球老化進一步加劇了這一需求，因為老年人在整個醫療保健過程中通常需要更密集的疼痛管理介入。此外，新興經濟體醫療基礎設施的改善和疼痛管理療法的普及也顯著促進了市場擴張。醫療保健專業人員對適當的疼痛管理方案和患者在治療過程中的舒適度重要性的認知不斷提高，也促使氫可酮在臨床實踐中的使用量增加。

然而，鴉片類藥物市場面臨許多限制因素，包括嚴格的處方法規結構、日益嚴重的鴉片類藥物成癮和成癮問題，以及全球監管機構日益嚴格的審查。鴉片類藥物危機迫使醫療系統實施更嚴格的處方指南，這可能會限制市場成長。此外，替代性疼痛管理療法和非鴉片類止痛藥的出現，對傳統的氫可酮類治療方法構成了競爭挑戰。儘管存在這些限制因素，市場仍蘊藏著巨大的成長機會。開發預防濫用的製劑，同時解決安全問題，為市場成長提供了一條充滿希望的途徑。在發展中地區擴大醫療保健服務覆蓋範圍，尤其是在疼痛管理基礎設施仍不完善的地區，蘊藏著巨大的市場潛力。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球醫用氫可酮市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球醫用氫可酮市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過利用全球醫用氫可酮市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第12章競爭格局

Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals plc
Sun Pharmaceutical Industries Ltd.
Johnson and Johnson
Viatris Inc.
Hikma Pharmaceuticals plc
Aurobindo Pharma Ltd.
Endo International plc
Mylan"¯NV（now Viatris）
Merck"¯KGaA
Bristol"'Myers Squibb Company
Grunenthal GmbH
Sanofi SA
AbbVie Inc.

第13章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第14章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8945

Medical Morphine Market is estimated to be valued at USD 27.13 Bn in 2026 and is expected to reach USD 46.19 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 27.13 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.90%	2033 Value Projection:	USD 46.19 Bn

The global medical morphine market represents a critical segment within the pharmaceutical industry, primarily focused on the production, distribution, and utilization of morphine-based medications for pain management and palliative care. Morphine, a naturally occurring opioid alkaloid derived from the opium poppy plant, serves as the gold standard for severe pain relief in clinical settings worldwide. This essential therapeutic agent plays an indispensable role in managing acute and chronic pain conditions, particularly in post-surgical care, cancer treatment, and end-of-life care scenarios.

The medical morphine market encompasses various formulations including immediate-release tablets, extended-release formulations, injectable solutions, and oral liquids, each designed to meet specific patient needs and clinical requirements. Healthcare providers rely heavily on morphine's potent analgesic properties to improve patient quality of life and ensure effective pain management protocols. The market's significance extends beyond mere revenue generation, as it directly impacts global healthcare outcomes and patient welfare. Despite regulatory challenges and concerns surrounding opioid dependency, medical morphine remains irreplaceable in modern medicine due to its unparalleled efficacy in severe pain management. The industry continues to evolve with advancing pharmaceutical technologies, improved delivery mechanisms, and enhanced safety profiles to maintain therapeutic benefits while minimizing potential risks.

Market Dynamics

The global medical morphine market is driven by several compelling factors that sustain its growth trajectory across international healthcare systems. The primary driver stems from the increasing prevalence of chronic pain conditions, cancer cases, and surgical procedures worldwide, creating substantial demand for effective pain management solutions. An aging global population further amplifies this demand, as elderly individuals typically require more intensive pain management interventions throughout their healthcare journey. Additionally, improved healthcare infrastructure in emerging economies and enhanced access to pain management therapies contribute significantly to market expansion. Growing awareness among healthcare professionals regarding proper pain management protocols and the importance of patient comfort during treatment has led to increased morphine utilization in clinical settings.

However, the market faces considerable restraints including stringent regulatory frameworks governing opioid prescriptions, growing concerns about opioid addiction and dependency, and increasing scrutiny from regulatory authorities worldwide. The opioid crisis has prompted healthcare systems to implement more restrictive prescribing guidelines, potentially limiting market growth. Furthermore, the emergence of alternative pain management therapies and non-opioid analgesics presents competitive challenges to traditional morphine-based treatments. Despite these restraints, significant opportunities exist within the market landscape. The development of abuse-deterrent formulations presents promising avenues for market growth while addressing safety concerns. Expanding healthcare access in developing regions offers untapped market potential, particularly in areas where pain management infrastructure is still developing.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global medical morphine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Viatris Inc., Hikma Pharmaceuticals plc, Aurobindo Pharma Ltd., Endo International plc, Mylan"¯N.V. (now Viatris), Merck"¯KGaA, Bristol"'Myers Squibb Company, Grunenthal GmbH, Sanofi S.A., and AbbVie Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global medical morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical morphine market

Market Segmentation

Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
Oral
Parenteral
Other routes (transdermal, suppository, intranasal, etc.)
Application Insights (Revenue, USD Bn, 2021 - 2033)
Cancer"'related pain management
Acute pain (post"'surgery, trauma, myocardial infarction)
Chronic pain (arthritis, musculoskeletal disorders)
Palliative and end"'of"'life care
Other applications (e.g., diarrhea suppression, cough suppression)
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals and Clinics
Ambulatory Surgical Centers
Homecare/Home Healthcare Settings
Other (rehabilitation centers, hospices)
Manufacturing Origin Insights (Revenue, USD Bn, 2021 - 2033)
Branded
Generic
Strength Insights (Revenue, USD Bn, 2021 - 2033)
Low"'dose (e.g.≤10"¯mg)
Medium"'dose (e.g.10"¯mg to ≤30"¯mg)
High"'dose (30"¯mg)
Patient Age Group Insights (Revenue, USD Bn, 2021 - 2033)
Pediatric
Adult
Geriatric
Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals plc
Sun Pharmaceutical Industries Ltd.
Johnson and Johnson
Viatris Inc.
Hikma Pharmaceuticals plc
Aurobindo Pharma Ltd.
Endo International plc
Mylan"¯N.V. (now Viatris)
Merck"¯KGaA
Bristol"'Myers Squibb Company
Grunenthal GmbH
Sanofi S.A.
AbbVie Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Medical Morphine Market, By Route of Administration
- Global Medical Morphine Market, By Application
- Global Medical Morphine Market, By End User
- Global Medical Morphine Market, By Manufacturing Origin
- Global Medical Morphine Market, By Strength
- Global Medical Morphine Market, By Patient Age Group
- Global Medical Morphine Market, By Distribution Channel
- Global Medical Morphine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Medical Morphine Market, By Route of Administration, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other routes (transdermal, suppository, intranasal, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Medical Morphine Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Cancer"'related pain management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Acute pain (post"'surgery, trauma, myocardial infarction)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Chronic pain (arthritis, musculoskeletal disorders)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Palliative and end"'of"'life care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other applications (e.g., diarrhea suppression, cough suppression)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Medical Morphine Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Homecare/Home Healthcare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other (rehabilitation centers, hospices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Medical Morphine Market, By Manufacturing Origin, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Medical Morphine Market, By Strength, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Low"'dose (e.g.≤10"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Medium"'dose (e.g.>10"¯mg to ≤30"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
High"'dose (>30"¯mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Medical Morphine Market, By Patient Age Group, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Medical Morphine Market, By Distribution Channel, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

11. Global Medical Morphine Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Manufacturing Origin, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

12. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mallinckrodt Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Hikma Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aurobindo Pharma Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mylan"¯N.V. (now Viatris)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck"¯KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bristol"'Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

13. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

14. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

氫可酮、Buprenornhine及其他藥物市場：按藥物、應用、給藥途徑、分銷管道和地區分類

氫可酮藥物市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

氫可酮市場規模、佔有率和成長分析（按劑型、分銷通路、應用、最終用戶和地區分類）－2026-2033年產業預測

FAQ

醫用氫可酮市場：依給藥途徑、應用、最終用戶、生產地、濃度、病患年齡層、通路和地區分類